2024-11-25 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

This report analyzes UnitedHealth Group Inc. (UNH), a leading healthcare and insurance company, based on the provided data.

**1. Performance Relative to S&P 500 (VOO):**

UNH's cumulative return (201.96%) significantly outperforms the S&P 500's cumulative return (127.58%).  The difference is 74.38%, placing it at the 46.97th percentile of its historical performance relative to the S&P 500. This indicates strong relative performance, though past performance is not indicative of future results.  The provided CAGR data further supports this, consistently showing higher growth rates than implied by the beta values (generally close to 1, suggesting similar market sensitivity), indicating positive alpha.

**2. Recent Price Movement:**

* **Closing Price:** $590.78 (Last Market: $606.11)
* **5-Day Moving Average:** $591.08
* **20-Day Moving Average:** $587.59
* **60-Day Moving Average:** $584.33

The price is slightly below the 5-day moving average, suggesting some minor near-term downward pressure. However, it remains above the 20-day and 60-day moving averages, indicating a generally upward trend. The difference between the last market price and closing price ($606.11 vs $590.78) represents a recent price drop, but not a significant crash or flash crash.

**3. Technical Indicators and Expected Return:**

* **RSI (61.08):**  Suggests the stock is neither overbought nor oversold, but approaching overbought territory.
* **PPO (-0.07):** A slightly negative PPO indicates a potentially weakening momentum.
* **Delta_Previous_Relative_Divergence (4.11 +):**  Shows a recent increase in relative strength.
* **Expected Return (36.54%):** This represents a significant potential outperformance compared to the S&P 500 over the long term (2+ years).

**4. Recent Financial Performance and Outlook:**

The provided earnings data shows fluctuating EPS and relatively stable revenue.  The negative EPS in Q2 2024 is noteworthy and requires further investigation into the underlying reasons.  The most recent EPS ($6.56) needs comparison against analyst estimates to determine whether it met, exceeded, or missed expectations.  Further context is needed regarding market expectations around these financials before drawing definitive conclusions on future performance.


| Date       | EPS   | Revenue (B$) |
|------------|-------|---------------|
| 2024-11-04 | 6.56  | 100.82        |
| 2024-08-09 | 4.58  | 98.86         |
| 2024-05-09 | -1.53 | 99.80         |
| 2023-11-06 | 6.31  | 92.36         |
| 2024-11-04 | 6.31  | 92.36         | *(Duplicate entry - assumed to be error)*


**5. Financial Information Analysis:**

The revenue has been relatively consistent, showing minor fluctuations quarter-over-quarter. Profit margins show some variation but generally remain high and indicate strong profitability.  Equity shows growth and ROE displays fluctuations, including a negative value in Q1 2024, requiring further analysis for understanding the contributing factors.

**6. News and Recent Issues:**

*(This section requires information from sources like Shacknews and Finbold. Please provide the relevant news articles for a comprehensive analysis.  Without this information, I cannot offer insights into recent market outlook, analyst opinions, and performance highlights.)*


**7. Overall Analysis:**

UNH has demonstrated strong historical outperformance relative to the S&P 500.  However, recent price action shows some minor weakening momentum.  Profitability remains strong, although the Q2 2024 EPS is concerning and needs further investigation. The high expected return suggests a positive long-term outlook, particularly for long-term investors.  The inclusion of relevant news and analyst opinions would significantly enhance this analysis and provide a more comprehensive picture.


**8.  Disclaimer:** This analysis is based solely on the data provided and is not a recommendation to buy or sell UNH stock.  Investing in the stock market involves risk, and past performance is not indicative of future results. Conduct thorough research and consult with a financial advisor before making any investment decisions.  The lack of detailed news analysis and analyst opinions limits the scope of this report.
